📰 Scienta Communications News
Page 3 - Scienta Communications News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Scienta Communications. Real-time updates on events, politics, business and more.
August 12, 2022
12.08.2022 - Paltusotine’s Phase 3 PATHFNDR Program in Acromegaly and Phase 2 Program in Carcinoid Syndrome Remain on Track for Top-Line Data in 2023 CRN04894 Phase 1 Data Demonstrated Pharmacologic Proof-of-Concept for Further Development in Both Cushing’s ...
July 12, 2022
SAN DIEGO, July 12, 2022 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on July 12, 2022, the Compensation...
June 2, 2022
Taking place on June 9 at 10:00 a.m. ETPURCHASE, N.Y., June 02, 2022 -- Cognition Therapeutics, Inc. , announced plans to hold a virtual KOL symposium on June 9, 2022, from 10:00 - 11:30 a.m. ET to... | June 2, 2022
May 17, 2022
Bio Path Holdings Inc. (NASDAQ:NASDAQ:BPTH) Q1 2022 Results Conference Call May 17, 2022 8:30 AM ET Company Participants Peter Nielsen - President, CEO Anthony Price - SVP, Finance,...
April 13, 2022
SAN DIEGO, April 12, 2022 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the...
March 23, 2022
Crinetics Pharmaceuticals Appoints Chris Robillard as Chief Business Officer - read this article along with other careers information, tips and advice on BioSpace
March 14, 2022
Crinetics Pharmaceuticals Appoints Caren Deardorf to Board of Directors SAN DIEGO, March 14, 2022 -- Crinetics Pharmaceuticals, Inc. , a clinical stage pharmaceutical... | March 14, 2022
March 10, 2022
Cognition Therapeutics to Present Analyses from Clinical Studies of CT1812 in Patients with Alzheimer’s Disease at AD/PD 2022 - read this article along with other careers information, tips and advice on BioSpace
March 10, 2022
SAN DIEGO, March 10, 2022 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the...
February 1, 2022
SAN DIEGO, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the...